Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Non-invasive Vagal Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients With Gastroparesis and Related Disorders

A legfontosabb adatok

Ki végzi
Johns Hopkins University
Hol
Baltimore (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Befejeződött
Résztvevők
49 fő vett részt
Kezdés
2021. ápr. 19.
Befejezés
2024. jan. 23.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • nVNS (gammaCore)
A regiszteradat frissítve
2024. október 15.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 19 feltétel megnézéseKevesebb

Ki vehet részt

  • Age 18 years or older at registration
  • Diagnosis of gastroparesis as documented by gastric emptying scintigraphy (4-hour emptying after a low-fat meal with any combination of 2- and 4-hour retention of >60% and 10%, respectively), or Chronic Unexplained Nausea and Vomiting (CUNV)
  • Ongoing symptoms (i.e. Nausea and vomiting, bloating, and abdominal pain) with a nausea score of 3 or more on the patient assessment of upper gastrointestinal disorders-symptom severity index (PAGI-SYM) scale at baseline (moderate to severe nausea)
  • Exclusion of other causes of symptoms such as mechanical gastrointestinal obstruction, uncontrolled esophagitis, peptic ulcer disease, etc. By standard radiographic or endoscopic tests
  • Use of the following medications on an as-needed basis: ondansetron, promethazine or prochlorperazine but no more than four times a day

Ki nem vehet részt

  • A previous surgery of the upper gastrointestinal tract, including vagotomy
  • Previous bilateral or right cervical vagotomy
  • Implanted with metal cervical spine hardware or has a metallic implant near the gammaCore stimulation site
  • Another active disorder, which could explain symptoms in the opinion of the investigator
  • Abnormal baseline ECG (e.g. Second- and third-degree heart block, atrial fibrillation, atrial flutter, recent history of ventricular tachycardia or ventricular fibrillation, or clinically significant premature ventricular contraction)
  • Currently implanted with an electrical and/or neurostimulator device, including but not limited to cardiac pacemaker or defibrillator, vagal neurostimulator, deep brain stimulator, spinal stimulator, bone growth stimulator, or cochlear implant
  • History of carotid endarterectomy or vascular neck surgery on the right side
  • Any other condition, which in the opinion of the investigator would impede compliance or hinder the completion of the study
  • Failure to give informed consent
  • History of prolonged QT interval or a history of clinically significant arrhythmia
  • Age < than 18 years
  • Pregnancy or nursing
  • Use of narcotics more than 3 days per week
  • Uncontrolled high blood pressure

Helyszínek itt: Egyesült Államok

  • Johns Hopkins Bayview Medical CenterBaltimore, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The hypothesis of this pilot study is that nVNS will result in relief of nausea by modulation of vagal nerve activity. nVNS is the first non-invasive, handheld medical device applied on the side of the neck and sends gentle, patented mild electrical stimulation through the skin to activate the vagus nerve. nVNS offers a potential alternative to Gastric electrical stimulation (GES) that could eliminate significant risks of injury or illness or identify likely responders to implantable neurostimulator including implanted VNS (iVNS). nVNS could provide a more effective and safer alternative to the use of traditional rescue medications.

A vizsgálat csoportja

  • nVNS deviceA vizsgált kezelés

    Candidates who, after the screening period are eligible to receive the nVNS device.

    Kezelés: nVNS (gammaCore)

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Publikációk
A regiszteradat frissítve
2024. október 15.